Segmented Collagen-Dextran Matrix for Surgical Adhesion Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Surgical adhesions, which are abnormal fibrous bands of scar tissue, frequently form after surgical procedures, leading to complications such as pain, infertility, and bowel obstruction, and current methods are inadequate in preventing or effectively treating these adhesions, as they often require additional surgeries that can exacerbate the issue.
Innovation Solution
A biodegradable polymer matrix comprising collagen and dextran is developed, with varying porosity layers to prevent cell infiltration and scar tissue formation, allowing for controlled release of dextran to inhibit adhesion growth, and can be applied as sheets or cylindrical tubes to specific surgical sites.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a single-layer adhesion barrier is used, then the device structure is simple, but the effectiveness in preventing cell infiltration and adhesion formation is insufficient
Solution Approach 1:
The adhesion barrier is divided into multiple layers with distinct functions: a first layer for initial barrier function and a second layer for sustained drug release. This segmentation allows each layer to be optimized for its specific purpose, improving overall effectiveness while maintaining manageable complexity
Solution Approach 2:
The device combines different materials in a composite structure - the first layer uses one material composition while the second layer uses a different material composition optimized for drug loading and release. This composite approach enables simultaneous achievement of barrier function and controlled drug delivery
2Reliability
If dextran is released quickly from the matrix, then the initial anti-adhesion effect is strong, but the sustained barrier function is reduced
Solution Approach 1:
The drug release function is segmented from the barrier function by placing dextran primarily in the second layer. This allows the first layer to provide immediate barrier protection while the second layer provides sustained drug release over time, resolving the contradiction between initial effect strength and duration
Solution Approach 2:
The first layer provides preliminary adhesion prevention action immediately upon implantation, while the second layer with dextran provides prolonged sustained action. This preliminary action followed by sustained action ensures both immediate and long-term effectiveness
3Quantity of substance
If the matrix is made highly porous to allow drug release, then dextran delivery is efficient, but cell infiltration into the matrix increases
Solution Approach 1:
The matrix is segmented into two layers with different porosity characteristics. The first layer has porosity optimized for barrier function with controlled cell infiltration, while the second layer has porosity optimized for dextran release. This segmentation allows each layer to fulfill its primary function without compromising the other
Solution Approach 2:
Different regions of the matrix have different local qualities - the first layer has quality optimized for cell barrier function while the second layer has quality optimized for drug release. This local differentiation allows simultaneous achievement of both barrier effectiveness and drug delivery efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The matrix effectively reduces and prevents adhesion formation by inhibiting cell infiltration and scar tissue growth, providing a sustained release of dextran to maintain an adhesion barrier, thereby reducing the need for subsequent surgeries and associated complications.
Implementation Method 1
The matrix is a foldable or flexible biodegradable polymer comprising a first porous layer comprising collagen and a second porous layer comprising collagen and dextran
Implementation Method 2
The matrix is configured to release from about 20% to about 90% of the dextran loaded in the matrix within 24 to 48 hours
Data Source
AI summary
Compositions and methods are provided for preparing an adhesion barrier in the form of a foldable or flexible biodegradable polymer matrix that effectively reduces, prevents or treats adhesions in a patient in need thereof. In one embodiment, the matrix comprises a first porous layer comprising collagen and a second porous layer comprising collagen and dextran, wherein the dextran is loaded in the second layer in an amount of from about 5% to about 90% by weight based on a total weight of the matrix. In some embodiments, the matrix prevents or reduces cell growth into the matrix so as to reduce or prevent adhesions. In some embodiments, the matrix is in a sheet or strip form that can be folded into a tube form.